Ian Roman Rifkin, Ph.D., M.B.,B.Ch.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interferon Regulatory Factors | 11 | 2021 | 280 | 3.770 |
Why?
|
| Lupus Erythematosus, Systemic | 18 | 2021 | 1997 | 2.320 |
Why?
|
| Antigen-Antibody Complex | 6 | 2009 | 547 | 1.080 |
Why?
|
| Dendritic Cells | 8 | 2020 | 2779 | 1.010 |
Why?
|
| Toll-Like Receptor 7 | 7 | 2017 | 151 | 1.000 |
Why?
|
| B-Lymphocytes | 11 | 2021 | 4913 | 0.970 |
Why?
|
| Toll-Like Receptor 9 | 13 | 2015 | 208 | 0.880 |
Why?
|
| Lupus Nephritis | 3 | 2017 | 316 | 0.840 |
Why?
|
| GTPase-Activating Proteins | 2 | 2014 | 487 | 0.820 |
Why?
|
| Autoimmune Diseases | 10 | 2010 | 2092 | 0.770 |
Why?
|
| PPAR gamma | 2 | 2014 | 500 | 0.730 |
Why?
|
| Thiazolidinediones | 2 | 2014 | 495 | 0.720 |
Why?
|
| Toll-Like Receptor 3 | 2 | 2015 | 77 | 0.700 |
Why?
|
| Interleukin-6 | 3 | 2021 | 3105 | 0.630 |
Why?
|
| Membrane Glycoproteins | 9 | 2015 | 3853 | 0.620 |
Why?
|
| Rheumatoid Factor | 5 | 2006 | 187 | 0.610 |
Why?
|
| CpG Islands | 4 | 2015 | 1151 | 0.580 |
Why?
|
| Toll-Like Receptors | 8 | 2017 | 591 | 0.580 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2015 | 331 | 0.540 |
Why?
|
| Autoimmunity | 8 | 2021 | 1309 | 0.540 |
Why?
|
| Helminth Proteins | 1 | 2015 | 179 | 0.530 |
Why?
|
| Mice, Knockout | 21 | 2019 | 15597 | 0.530 |
Why?
|
| Receptors, Cell Surface | 7 | 2005 | 2944 | 0.530 |
Why?
|
| Arthritis, Experimental | 1 | 2015 | 288 | 0.520 |
Why?
|
| Receptors, IgG | 2 | 2009 | 613 | 0.520 |
Why?
|
| Podocytes | 1 | 2017 | 408 | 0.510 |
Why?
|
| Atherosclerosis | 5 | 2015 | 2958 | 0.510 |
Why?
|
| Nucleic Acids | 1 | 2014 | 147 | 0.490 |
Why?
|
| Immunoglobulin G | 9 | 2009 | 4297 | 0.490 |
Why?
|
| Mice, Inbred MRL lpr | 9 | 2014 | 177 | 0.480 |
Why?
|
| Lymphocyte Activation | 11 | 2009 | 5989 | 0.470 |
Why?
|
| Autoantigens | 5 | 2017 | 914 | 0.440 |
Why?
|
| Myeloid Cells | 1 | 2015 | 813 | 0.420 |
Why?
|
| Interferon-alpha | 5 | 2017 | 925 | 0.410 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2009 | 10 | 0.410 |
Why?
|
| Interferon-beta | 2 | 2009 | 338 | 0.410 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2015 | 567 | 0.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2021 | 4477 | 0.400 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 2009 | 770 | 0.370 |
Why?
|
| Mice | 36 | 2021 | 80803 | 0.370 |
Why?
|
| Interferon Type I | 2 | 2010 | 507 | 0.350 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2007 | 40 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 17 | 2017 | 23439 | 0.340 |
Why?
|
| Disease Models, Animal | 15 | 2021 | 18495 | 0.330 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2006 | 545 | 0.320 |
Why?
|
| DNA | 7 | 2015 | 7320 | 0.300 |
Why?
|
| Immunologic Factors | 1 | 2015 | 1477 | 0.290 |
Why?
|
| RNA | 4 | 2007 | 2493 | 0.280 |
Why?
|
| Animals | 41 | 2021 | 170849 | 0.280 |
Why?
|
| DNA-Binding Proteins | 6 | 2007 | 9934 | 0.270 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2003 | 247 | 0.250 |
Why?
|
| Ligands | 7 | 2017 | 3189 | 0.240 |
Why?
|
| Adiponectin | 1 | 2009 | 1098 | 0.240 |
Why?
|
| Fas Ligand Protein | 4 | 2013 | 230 | 0.230 |
Why?
|
| Autoantibodies | 7 | 2014 | 1925 | 0.230 |
Why?
|
| Th2 Cells | 5 | 2020 | 1036 | 0.230 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2003 | 293 | 0.220 |
Why?
|
| Monocytes | 3 | 2015 | 2643 | 0.220 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2249 | 0.210 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 3492 | 0.210 |
Why?
|
| Epitopes | 1 | 2007 | 2716 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2019 | 123 | 0.200 |
Why?
|
| Apolipoproteins E | 4 | 2014 | 1403 | 0.200 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2014 | 576 | 0.190 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2020 | 79 | 0.190 |
Why?
|
| Spleen | 3 | 2014 | 2570 | 0.190 |
Why?
|
| Antibodies, Antinuclear | 3 | 2015 | 336 | 0.190 |
Why?
|
| Chromatin | 4 | 2004 | 2503 | 0.190 |
Why?
|
| Cytokines | 6 | 2020 | 7147 | 0.190 |
Why?
|
| Germinal Center | 1 | 2021 | 354 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4355 | 0.180 |
Why?
|
| Th1 Cells | 4 | 2014 | 1065 | 0.170 |
Why?
|
| Immunoglobulin E | 1 | 2003 | 1448 | 0.170 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2017 | 58 | 0.160 |
Why?
|
| Toll-Like Receptor 8 | 2 | 2015 | 90 | 0.160 |
Why?
|
| Spores, Bacterial | 1 | 2017 | 114 | 0.160 |
Why?
|
| Mice, Transgenic | 9 | 2017 | 10094 | 0.160 |
Why?
|
| Proteinuria | 2 | 2017 | 609 | 0.160 |
Why?
|
| Rolipram | 1 | 2015 | 28 | 0.150 |
Why?
|
| Signal Transduction | 9 | 2021 | 24351 | 0.150 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2015 | 44 | 0.150 |
Why?
|
| Osmosis | 2 | 2015 | 124 | 0.150 |
Why?
|
| RNA, Bacterial | 1 | 2017 | 406 | 0.140 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2015 | 39 | 0.140 |
Why?
|
| Transgenes | 1 | 1998 | 1037 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2015 | 260 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1998 | 542 | 0.140 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 2 | 1993 | 29 | 0.140 |
Why?
|
| B-Cell Activating Factor | 1 | 2014 | 127 | 0.140 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2014 | 159 | 0.140 |
Why?
|
| Synovial Fluid | 1 | 2015 | 361 | 0.130 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2015 | 339 | 0.130 |
Why?
|
| Neutrophil Activation | 1 | 2014 | 232 | 0.130 |
Why?
|
| Th17 Cells | 1 | 2020 | 705 | 0.130 |
Why?
|
| Inflammasomes | 1 | 2017 | 384 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 4 | 2009 | 6786 | 0.120 |
Why?
|
| Macrophages | 4 | 2019 | 5748 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 1498 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2003 | 3150 | 0.120 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 1993 | 128 | 0.120 |
Why?
|
| Cells, Cultured | 8 | 2015 | 20620 | 0.110 |
Why?
|
| Macrophage Activation | 1 | 2015 | 589 | 0.110 |
Why?
|
| Mycophenolic Acid | 1 | 2013 | 351 | 0.110 |
Why?
|
| Poly I-C | 1 | 2010 | 105 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1761 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1826 | 0.100 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 2536 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 944 | 0.100 |
Why?
|
| Rhabdomyolysis | 1 | 1991 | 152 | 0.100 |
Why?
|
| Flow Cytometry | 3 | 2017 | 6230 | 0.100 |
Why?
|
| Nucleosomes | 2 | 2004 | 459 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 256 | 0.090 |
Why?
|
| Models, Immunological | 2 | 2004 | 542 | 0.090 |
Why?
|
| Dermatitis | 1 | 2010 | 193 | 0.090 |
Why?
|
| Hybridomas | 2 | 2006 | 454 | 0.090 |
Why?
|
| Levocardia | 1 | 1987 | 2 | 0.090 |
Why?
|
| Immunosuppressive Agents | 3 | 2013 | 4208 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 12680 | 0.090 |
Why?
|
| Cell-Free System | 1 | 2009 | 387 | 0.090 |
Why?
|
| Fibrosis | 1 | 2015 | 1798 | 0.090 |
Why?
|
| Immunity, Innate | 3 | 2010 | 2892 | 0.090 |
Why?
|
| Lithium | 1 | 1991 | 620 | 0.090 |
Why?
|
| Scleroderma, Systemic | 1 | 2010 | 279 | 0.080 |
Why?
|
| Neutrophils | 3 | 2014 | 3876 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 2 | 2009 | 904 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 488 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 5114 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 16227 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4115 | 0.080 |
Why?
|
| Apoptosis | 4 | 2015 | 10261 | 0.080 |
Why?
|
| Splenomegaly | 2 | 2013 | 204 | 0.080 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2006 | 259 | 0.070 |
Why?
|
| Humans | 38 | 2021 | 686663 | 0.070 |
Why?
|
| DNA Primers | 3 | 2006 | 3121 | 0.070 |
Why?
|
| Mutation | 4 | 2014 | 28848 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1307 | 0.070 |
Why?
|
| Glomerulonephritis | 1 | 2006 | 381 | 0.070 |
Why?
|
| Lymphatic Diseases | 2 | 2013 | 330 | 0.070 |
Why?
|
| Vena Cava, Inferior | 1 | 1987 | 456 | 0.070 |
Why?
|
| Lymphocyte Depletion | 1 | 2006 | 652 | 0.070 |
Why?
|
| Immunoglobulin M | 3 | 2006 | 1494 | 0.070 |
Why?
|
| Simvastatin | 1 | 2006 | 350 | 0.070 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 650 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2014 | 2099 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2020 | 1577 | 0.060 |
Why?
|
| Gene Expression | 2 | 2014 | 8182 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2003 | 11910 | 0.060 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 1778 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 4076 | 0.060 |
Why?
|
| Macrolides | 1 | 2004 | 222 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 878 | 0.060 |
Why?
|
| Base Sequence | 4 | 2015 | 13729 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 1977 | 0.060 |
Why?
|
| STAT1 Transcription Factor | 1 | 2003 | 354 | 0.060 |
Why?
|
| Aging | 1 | 2021 | 8222 | 0.060 |
Why?
|
| Psoriasis | 1 | 2009 | 939 | 0.050 |
Why?
|
| Immunoglobulin Allotypes | 1 | 2000 | 59 | 0.050 |
Why?
|
| Skin | 1 | 2015 | 4456 | 0.050 |
Why?
|
| Haptens | 1 | 2000 | 186 | 0.050 |
Why?
|
| T-Box Domain Proteins | 1 | 2003 | 476 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2014 | 10766 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 6323 | 0.050 |
Why?
|
| Immune Sera | 1 | 2000 | 794 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2004 | 1354 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 1971 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2006 | 2698 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 1250 | 0.050 |
Why?
|
| Phenotype | 3 | 2013 | 16091 | 0.050 |
Why?
|
| Casein Kinase II | 1 | 1998 | 122 | 0.050 |
Why?
|
| Histocompatibility Testing | 1 | 2000 | 832 | 0.050 |
Why?
|
| Cattle | 1 | 2004 | 4017 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2006 | 3425 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1757 | 0.040 |
Why?
|
| Male | 12 | 2021 | 352465 | 0.040 |
Why?
|
| Bacillus anthracis | 1 | 2017 | 123 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 17251 | 0.040 |
Why?
|
| Progesterone | 3 | 1977 | 731 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2009 | 3987 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2000 | 1332 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 996 | 0.040 |
Why?
|
| Cell Line | 2 | 2009 | 17137 | 0.040 |
Why?
|
| Genotype | 1 | 2009 | 13073 | 0.030 |
Why?
|
| Diphtheria Toxin | 1 | 2015 | 265 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2015 | 3263 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 2015 | 210 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 2009 | 0.030 |
Why?
|
| Homozygote | 1 | 1998 | 1855 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 290 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1942 | 0.030 |
Why?
|
| Dialysis Solutions | 1 | 1993 | 31 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 469 | 0.030 |
Why?
|
| Female | 14 | 2021 | 375459 | 0.030 |
Why?
|
| Calcium Carbonate | 1 | 1993 | 69 | 0.030 |
Why?
|
| Nephritis | 1 | 2013 | 149 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2015 | 689 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 1999 | 1364 | 0.030 |
Why?
|
| Inflammation | 2 | 2015 | 9617 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3998 | 0.030 |
Why?
|
| Renal Veins | 1 | 1992 | 112 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 1987 | 4132 | 0.030 |
Why?
|
| Ovary | 2 | 1976 | 1016 | 0.030 |
Why?
|
| Heterozygote | 1 | 1998 | 2787 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2007 | 8882 | 0.030 |
Why?
|
| Liver | 1 | 1987 | 7653 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 12095 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2014 | 4441 | 0.030 |
Why?
|
| Antigens, Differentiation | 2 | 2005 | 991 | 0.030 |
Why?
|
| Postpartum Period | 2 | 1977 | 907 | 0.030 |
Why?
|
| Lithium Carbonate | 1 | 1991 | 193 | 0.030 |
Why?
|
| Chemokines | 1 | 2015 | 958 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 1993 | 422 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 2103 | 0.030 |
Why?
|
| Calcium | 2 | 1994 | 5696 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1996 | 1626 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2005 | 548 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1998 | 1914 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1972 | 541 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2015 | 10990 | 0.020 |
Why?
|
| Renal Artery | 1 | 1992 | 419 | 0.020 |
Why?
|
| Phosphates | 1 | 1993 | 764 | 0.020 |
Why?
|
| Thalidomide | 1 | 1995 | 907 | 0.020 |
Why?
|
| Magnesium | 1 | 1993 | 864 | 0.020 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2010 | 80 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1995 | 986 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1992 | 291 | 0.020 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2009 | 127 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2015 | 1209 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9661 | 0.020 |
Why?
|
| Dermis | 1 | 2010 | 214 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 2503 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2000 | 2708 | 0.020 |
Why?
|
| Immune System Diseases | 1 | 2010 | 260 | 0.020 |
Why?
|
| Estrogens | 1 | 1975 | 1476 | 0.020 |
Why?
|
| Amenorrhea | 1 | 1972 | 492 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8896 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 1516 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1889 | 0.020 |
Why?
|
| Receptors, Immunologic | 2 | 2005 | 1476 | 0.020 |
Why?
|
| Corpus Luteum | 2 | 1977 | 86 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2923 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6464 | 0.020 |
Why?
|
| Cholesterol | 2 | 2006 | 2751 | 0.020 |
Why?
|
| Eating | 1 | 2013 | 1429 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 955 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 1993 | 1841 | 0.020 |
Why?
|
| Hematuria | 1 | 2006 | 230 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1993 | 3385 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 15075 | 0.020 |
Why?
|
| Prognosis | 1 | 2006 | 28923 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 1991 | 906 | 0.020 |
Why?
|
| Immune System | 1 | 2010 | 813 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2000 | 9863 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2000 | 10329 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2004 | 199 | 0.020 |
Why?
|
| Ovulation | 2 | 1976 | 192 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 717 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 59331 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 8895 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 5044 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 413 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 1162 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2005 | 3006 | 0.020 |
Why?
|
| Kinetics | 2 | 2006 | 6979 | 0.010 |
Why?
|
| Receptors, Complement 3b | 1 | 2002 | 149 | 0.010 |
Why?
|
| Receptors, Complement 3d | 1 | 2002 | 134 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4804 | 0.010 |
Why?
|
| Mammals | 1 | 2006 | 688 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 2002 | 233 | 0.010 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 2 | 1994 | 239 | 0.010 |
Why?
|
| Chloroquine | 1 | 2003 | 275 | 0.010 |
Why?
|
| Adult | 6 | 2021 | 211400 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1939 | 0.010 |
Why?
|
| Creatinine | 1 | 2006 | 1844 | 0.010 |
Why?
|
| Kidney Transplantation | 2 | 1992 | 4015 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1992 | 2467 | 0.010 |
Why?
|
| Wasting Syndrome | 1 | 2000 | 105 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1993 | 4686 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4436 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2010 | 4345 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 1991 | 1788 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 5257 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 17071 | 0.010 |
Why?
|
| Relaxin | 1 | 1977 | 28 | 0.010 |
Why?
|
| Middle Aged | 4 | 2021 | 216468 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2004 | 1141 | 0.010 |
Why?
|
| Mites | 1 | 1996 | 46 | 0.010 |
Why?
|
| Menotropins | 1 | 1976 | 45 | 0.010 |
Why?
|
| Bee Venoms | 1 | 1996 | 19 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 162271 | 0.010 |
Why?
|
| Mitogens | 1 | 1996 | 266 | 0.010 |
Why?
|
| Fertility Agents, Female | 1 | 1976 | 98 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 1312 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13204 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 2133 | 0.010 |
Why?
|
| Estrone | 1 | 1975 | 215 | 0.010 |
Why?
|
| Calcimycin | 1 | 1994 | 233 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1976 | 443 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 1994 | 157 | 0.010 |
Why?
|
| Polyarteritis Nodosa | 1 | 1994 | 71 | 0.010 |
Why?
|
| Dust | 1 | 1996 | 462 | 0.010 |
Why?
|
| Menarche | 1 | 1976 | 489 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1991 | 4998 | 0.010 |
Why?
|
| Norethynodrel | 1 | 1972 | 2 | 0.010 |
Why?
|
| Mestranol | 1 | 1972 | 9 | 0.010 |
Why?
|
| Ethynodiol Diacetate | 1 | 1972 | 5 | 0.010 |
Why?
|
| 17-Ketosteroids | 1 | 1972 | 47 | 0.010 |
Why?
|
| Cervix Mucus | 1 | 1972 | 19 | 0.010 |
Why?
|
| Sperm Capacitation | 1 | 1972 | 29 | 0.010 |
Why?
|
| Receptors, Somatotropin | 1 | 1992 | 75 | 0.010 |
Why?
|
| Norethindrone | 1 | 1972 | 60 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1993 | 448 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1992 | 734 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1995 | 856 | 0.010 |
Why?
|
| Estradiol | 2 | 1976 | 1994 | 0.010 |
Why?
|
| Renal Circulation | 1 | 1992 | 357 | 0.010 |
Why?
|
| Cesarean Section | 2 | 1977 | 1233 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1993 | 520 | 0.010 |
Why?
|
| Ultrasonics | 1 | 1992 | 228 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 15296 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1992 | 681 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1972 | 742 | 0.010 |
Why?
|
| Endometrium | 1 | 1972 | 400 | 0.010 |
Why?
|
| Body Temperature | 1 | 1972 | 801 | 0.010 |
Why?
|
| Parity | 1 | 1972 | 876 | 0.010 |
Why?
|
| Allergens | 1 | 1996 | 1229 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1996 | 963 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1992 | 1486 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1972 | 1899 | 0.010 |
Why?
|
| Kidney | 2 | 1992 | 6744 | 0.000 |
Why?
|
| Propylene Glycol | 1 | 1946 | 24 | 0.000 |
Why?
|
| Stem Cells | 1 | 2000 | 3612 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1992 | 1601 | 0.000 |
Why?
|
| Penicillins | 1 | 1946 | 346 | 0.000 |
Why?
|
| Time Factors | 2 | 1996 | 42271 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1993 | 4256 | 0.000 |
Why?
|
| Biopsy | 1 | 1992 | 6849 | 0.000 |
Why?
|
| Pregnancy | 2 | 1977 | 25703 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1992 | 5876 | 0.000 |
Why?
|
| Abortion, Legal | 1 | 1977 | 77 | 0.000 |
Why?
|
| Stimulation, Chemical | 1 | 1976 | 356 | 0.000 |
Why?
|
| Haplorhini | 1 | 1976 | 602 | 0.000 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1977 | 707 | 0.000 |
Why?
|
| Sexual Maturation | 1 | 1976 | 248 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1976 | 2418 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1992 | 15083 | 0.000 |
Why?
|
| Alkenes | 1 | 1946 | 62 | 0.000 |
Why?
|